BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
October 30, 2012 at 07:39 AM EDT
ArQule (ARQL) Reports Tivantinib Licensee Hakko Kirin Discontinues Phase 3 ATTENTION
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7826722 for the full story.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here